SEP’s mission is to become a leading pan European urology and urogynaecology focused specialty pharmaceutical business.
The urology/urogynaecology market is highly specialist driven and our focus is on developing an attractive portfolio of products owned by the Company, such as Bulkamid and Mitem, as well as being a partner of choice for others looking to maximize the European sales of their products.
We are seeking urological and/or urogynaecological products (drugs, devices or diagnostics), that are in phase III, registration or in-market.
Our team is experienced in bringing products through to the European market. We have direct experience in all aspects required to drive a successful specialty pharmaceutical business: